Steve Clifford

You can also find me - and a rapidly growing number of interesting cancer folk - on Bluesky Social @ProfSClifford.bsky.social

Merry Christmas Everyone! This year, instead of Christmas cards, I’ve donated to the wonderful ‘Children with Cancer in Malawi’ charity justgiving.com/charity/childr…. You could do the same if you’re interested?! Wishing you all a happy and healthy 2026!

We're delighted to share that @UniofNewcastle has officially approved renewal of the #NUCancerCentre for 2025-30. We look forward to continuing this important journey together over the next five years.

I’m pleased to be speaking at the @CRUKresearch’s upcoming children’s & young people’s cancers webinar on exploring further discoveries from clinical research. Join me on 12 February from 3–4:30 pm (GMT): #ExploringCYPCancers" target="_blank" rel="nofollow noopener">bit.ly/3BsXMF0#Explor… @NU_Cancer

🚨 Less than one week left until our #ExploringCYPCancers webinar. Join researchers at the interface between clinical & discovery research discussing how to learn more from #ClinicalTrials to improve outcomes for children’s & young people’s cancers 👉 bit.ly/3BsXMF0

📣Announcing more speakers at our upcoming #ExploringCYPCancers webinar on clinical research: 💡Steve Clifford (@NU_Cancer) 💡John Rainsbury (Little Hero) Join us on 12 Feb, 3–4:30 pm to explore how to maximise learning from #ClinicalTrials: bit.ly/3BsXMF0 @ProfSClifford | @UniofNewcastle | @JohnRainsbury

PhD post available: Are you interested in using contemporary ‘omics approaches to uncover clinically-relevant biology in medulloblastoma, the most common malignant brain tumour in children? Join our Childhood Brain Tumour Research team @nu_cancer See findaphd.com/phds/project/p…

Looking for a PhD? Our multi-disciplinary team @NU_Cancer are using next-generation 'omics, AI, bioinformatics and biostatistics across pan-European clinical trials to improve outcomes for children with #medulloblastoma. See findaphd.com/phds/project/m… or DM if you're interested.

Exciting PhD opportunity seeking to reduce the therapy-associated late-effects burden in childhood cancer survivors, in our internationally-leading childhood cancer centre! @NU_Cancer @ChildCancerNTH @halsey_lab @DelFred010530 eur03.safelinks.protection.outlook.com/?url=https%3A%…

We're proud to announce over 700 scholarships for international and EU students, welcoming applications from students of diverse backgrounds from across the world to support them in pursuing their degrees! 🎺🌎 Read more here. ⬇ #WeAreNCL ncl.ac.uk/press/articles…

Vital research led by our own Professor Steve Clifford could lead to treatments that improve survival rates of children diagnosed with Medulloblastoma, which is responsible for around 5% to 10% of childhood cancer deaths. 🔬 Read more here. ⬇ #WeAreNCL ncl.ac.uk/press/articles…

Studies find more targeted approach to treating childhood brain cancer ncl.ac.uk/press/articles… @NU_Cancer @UniofNewcastle @NCL_medscience @SIOPEurope @CCLG_UK @ITCC_eu

Out now.....MYC-dependent upregulation of the serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma academic.oup.com/neuro-oncology… Great job Maggie and our amazing collabs @NU_Cancer @CwC_UK @BrainTumourOrg @GOSHCharity @ChildCancerNTH

Just published 2: Heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcome - picking out the bad actors from >1600 patients academic.oup.com/neuro-oncology… Well done @edschwalbe et al @NU_Cancer @CRUKresearch @CwC_UK @BrainTumourOrg @GOSHCharity

Revealing the 'worst of the worst' #medulloblastoma - new treatments urgently needed: Heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcome academic.oup.com/neuro-oncology… @edschwalbe @NU_Cancer @CRUKresearch @CwC_UK @BrainTumourOrg @GOSHCharity

If you don't know..... @rushtheband

If you know.....